Skip to main content
Clinical Trials/NCT00394784
NCT00394784
Withdrawn
Not Applicable

Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream Isolates

University of Pittsburgh1 site in 1 countryDecember 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gram-negative Bacterial Infections
Sponsor
University of Pittsburgh
Locations
1
Primary Endpoint
dead or alive
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

This research is important because it allows for the determination of resistance rates to antibiotics that may not be frequently tested by the clinical microbiology laboratory at University of Pittsburgh Medical Center (UPMC)-Presbyterian. It also will provide antibiotic minimum inhibitory concentrations (MICs) for these pathogens which may help in identifying the best empiric antibiotic option for gram-negative blood stream infections based on known pharmacodynamic parameters.

Detailed Description

Bacterial cultures will be ordered in the normal clinical course of the management of patients in the liver transplant ICU by the medical team. These cultures are then processed by the clinical Microbiology laboratory in the normal manner. If these cultures grow a Gram-negative bacteria, they are eligible for this study. Typically the clinical Microbiology laboratory saves these bacteria for a period of time after the final microbiology report. At this time, unless asked otherwise, the bacteria will be placed in biohazardous waste containers for proper disposal. If these cultures have grown a Gram-negative bacteria, they are eligible for this study, and will not be disposed of but will be given to the investigators without identifiers for this study. The antibiotic susceptibility of these organisms will be tested by the investigators in a separate research laboratory. Mechanisms of antibiotic resistance may also be assessed.

Registry
clinicaltrials.gov
Start Date
December 2006
End Date
December 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Brian Potoski

Pharm D

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

  • Patients with positive gram-negative bacteria

Exclusion Criteria

  • Less than 18 years of age

Outcomes

Primary Outcomes

dead or alive

Time Frame: end of study

health status

Study Sites (1)

Loading locations...

Similar Trials